Recent Updates
Recently added Catalysts
AMGN

Amgen To Present At The Morgan Stanley Global Healthcare Conference Amgen (NASDAQ:AMGN) will present at the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 12, 2012 at the Grand Hyatt in New York City, ...

Key Takeaway: THOUSAND OAKS, Calif. , Sept. 7, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 12, 2012 at the Grand Hyatt in New York City , beginning at 2:10 p.m. Eastern Daylight Time . Jonathan M. Peacock , exec

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Sept. 7, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 12, 2012 at the Grand Hyatt in New York City , beginning at 2:10 p.m. Eastern Daylight Time . Jonathan M. Peacock , executive vice president and chief financial officer at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Arvind Sood , 805-447-1060 (investors)
Last updated: Sep 7, 2012